Russia fully complies with terms of oil production cut deal — Energy MinistryBusiness & Economy June 27, 14:29
Kremlin has no information about pending chemical attacks in SyriaRussian Politics & Diplomacy June 27, 14:26
European Commission fines Google record 2.4 bln euro for abusing dominanceBusiness & Economy June 27, 13:38
Moscow calls to resume dialogue in NATO-Russia Council with participation of militaryRussian Politics & Diplomacy June 27, 13:38
Kremlin does not monitor Russian companies foreign business operationsBusiness & Economy June 27, 13:32
Russian intelligence chief extols covert operatives as cream of the cropRussian Politics & Diplomacy June 27, 13:16
Kremlin disagrees with Macron’s remarks on UkraineRussian Politics & Diplomacy June 27, 13:09
Press review: Macron's Donbass peace plan and Assad no longer the 'bad guy'Press Review June 27, 13:00
Charlie Chaplin’s grandson to perform at Moscow International Chekhov’s FestivalSociety & Culture June 27, 12:57
MOSCOW, November 21. /ITAR-TASS/. The Russian Health Ministry has expressed concern over a big number of pharmacies in Russia, which provokes price dumping policies and lowers pharmacy quality standards, Health Minister Veronika Skvortsova told the Presidium of the Russian government on Thursday.
The Russian pharmacy market has a huge number of economic entities running the production and distribution sectors. A total of 550 organizations and a thousand foreign pharmacies have licenses for medicine production and deliveries, Skvortsova said with reference to the Single License Register of the Russian Ministry of Industry and Trade.
In Russia, there is one pharmacy per every 1,450 people, in the United States - one pharmacy per every 4,500 people and in Germany - one pharmacy per 3,900 people, she said. There is a surplus number of pharmacies in Russia; the quality of pharmacy services is worsening; the share of pharmacies capable to produce medicines or which have the necessary conditions for the storage of medicines and narcotic-containing stuff has been declining, Skvortsova said.
Creation of vertically integrated structures and large pharmacy networks hinders the development of a competitive environment, provokes price dumping and creates problems for producers of medicines, Skvortsova said.